TABLE 1

Baseline characteristics of 328 patients with type 2 diabetes

SurvivedDied
n215113
Age (years)51.7 ± 9.157.9 ± 6.2
Sex (% men)58.667.3
BMI (kg/m2)28.5 ± 5.029.0 ± 5.2
Smoking (never/ former/current %)29.8/25.1/45.124.8/24.8/50.4
Diabetes duration (years)5.0 (2.0–10.0)9.0 (5.0–14.0)
Diabetes treatment (diet/insulin/other %)41.9/16.7/41.523.0/39.9/37.2
Blood pressure (mmHg)
 Systolic146.1 ± 21.4159.7 ± 22.5
 Diastolic84.9 ± 11.287.3 ± 12.4
Hypertension (%)45.167.3
Antihypertensive drug treatment (%)31.648.7
Serum total cholesterol (mmol/l)6.0 (5.1–6.9)6.7 (5.4–7.9)
Serum HDL cholesterol (mmol/l)1.0 (0.9–1.2)1.0 (0.8–1.3)
Serum triglycerides (mmol/l)1.7 (1.2–2.8)2.2 (1.4–3.5)
HbA1c (%)7.6 (6.4–9.1)8.6 (7.1–9.8)
Prior cardiovascular disease (%)3.322.1
Retinopathy (background/ proliferative %)22.8/2.344.2/7.1
Serum creatinine (μmol/l)73.0 (63.0–85.0)81.0 (69.5–98.0)
Urinary albumin excretion (mg/24 h)13.0 (6.0–44.0)61.0 (14.0–245.0)
Normo-/micro-/macroalbuminuria (%)70.7/20.5/8.834.5/41.6/23.9
Plasma von Willebrand factor (%)83.6 (54.9–112.2)112.8 (69.2–139.9)
Plasma tissue-type plasminogen activator (μg/l)6.3 (4.2–9.7)7.2 (4.8–11.0)
Plasma soluble vascular cell adhesion molecule 1 (μg/l)640 (443–946)881 (588–1,295)
Plasma soluble E-selectin (μg/l)64.1 (42.9–88.4)65.6 (47.6–97.0)
Plasma C-reactive protein (mg/l)2.9 (0.9–5.9)4.8 (2.2–10.5)
  • Data are means ± SD or medians (25th–75th percentile) unless otherwise indicated.